GE VERNOVA ($GEV) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $0.91 per share, beating estimates of $0.41 by $0.50. The company also reported revenue of $8,032,000,000, beating estimates of $7,618,647,442 by $413,352,558.
You can see Quiver Quantitative's $GEV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GE VERNOVA Hedge Fund Activity
We have seen 918 institutional investors add shares of GE VERNOVA stock to their portfolio, and 684 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MOUNTAINEER PARTNERS MANAGEMENT, LLC removed 9,803,930 shares (-99.7%) from their portfolio in Q4 2024, for an estimated $3,224,806,694
- VANGUARD GROUP INC removed 3,540,221 shares (-12.9%) from their portfolio in Q4 2024, for an estimated $1,164,484,893
- CAPITAL INTERNATIONAL INVESTORS added 2,994,660 shares (+25.3%) to their portfolio in Q4 2024, for an estimated $985,033,513
- EAGLE CAPITAL MANAGEMENT LLC removed 2,104,243 shares (-50.4%) from their portfolio in Q4 2024, for an estimated $692,148,649
- MARSHALL WACE, LLP removed 1,720,126 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $565,801,045
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,638,606 shares (-29.5%) from their portfolio in Q4 2024, for an estimated $538,986,671
- FRANKLIN RESOURCES INC removed 1,415,599 shares (-71.5%) from their portfolio in Q4 2024, for an estimated $465,632,979
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GE VERNOVA Government Contracts
We have seen $2,760,926 of award payments to $GEV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- ZENITH PHASE 2,THE PRIMARY GOALS OF THE ZENITH PROGRAM ARE TO DESIGN, BUILD AND PROVE GROUND-BASED, TILTABL...: $1,448,382
- EXPERIMENTALLY VALIDATED CO-ELECTROLYSIS MODEL DEVELOPMENT FOR SYNTHETIC FUEL PRODUCTION: $1,312,544
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
GE VERNOVA Congressional Stock Trading
Members of Congress have traded $GEV stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GEV stock by members of Congress over the last 6 months:
- REPRESENTATIVE LAUREL M. LEE sold up to $50,000 on 11/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GE VERNOVA Analyst Ratings
Wall Street analysts have issued reports on $GEV in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Susquehanna issued a "Positive" rating on 04/02/2025
- Jefferies issued a "Buy" rating on 03/27/2025
- Guggenheim issued a "Buy" rating on 03/05/2025
- Goldman Sachs issued a "Buy" rating on 01/23/2025
- Barclays issued a "Overweight" rating on 01/23/2025
- RBC Capital issued a "Outperform" rating on 11/13/2024
- Daiwa issued a "Buy" rating on 10/30/2024
To track analyst ratings and price targets for GE VERNOVA, check out Quiver Quantitative's $GEV forecast page.
GE VERNOVA Price Targets
Multiple analysts have issued price targets for $GEV recently. We have seen 7 analysts offer price targets for $GEV in the last 6 months, with a median target of $380.0.
Here are some recent targets:
- Charles Minervino from Susquehanna set a target price of $370.0 on 04/02/2025
- An analyst from Truist Financial set a target price of $440.0 on 03/27/2025
- An analyst from RBC Capital set a target price of $445.0 on 03/18/2025
- An analyst from New Street set a target price of $380.0 on 03/05/2025
- An analyst from Guggenheim set a target price of $380.0 on 03/05/2025
- Maheep Mandloi from Mizuho Securities set a target price of $351.0 on 12/02/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.